Southern Research is a nonprofit contract research organization with more than 80 years of experience in drug discovery and development. We have helped shape modern oncology treatment by developing 7 FDA-approved cancer-fighting drugs and testing half of active chemotherapies on the market. With state-of-the-art BSL-3 facilities, SR also has deep expertise in infectious disease research and has conducted more than $35M in COVID-19 research alongside industry partners. Our team of industry-leading experts provides personalized support to our clients. Whether you’re looking for discovery research assistance, IND-enabling toxicology, or clinical trial support, SR offers competitive timelines to advance your program efficiently and effectively.

Southern Research Institute offers
Therapeutic Discovery
Hit Identification
Hit-to-lead Optimization
Discovery ADME,
Bioanalytical Informatics
Medicinal Chemistry Support
Immunophenotyping
Functional Assays
Customized Assays
GLP Toxicology
Efficacy Studies (BSL-3 Capabilities)
Tumor Xenograft Models
IND-Enabling Studies in Rodent to NHP Animal Models